International Journal of Infectious Diseases · 2021 · 57 citations · 18 references
PharmacyPharmacokineticsPharmacologyClinical PharmacologyPharmaceutical ToxicologyPharmacodynamicsDrug DispositionPharmacoepidemiologyTuberculosis PharmacotherapyMultidrug-resistant OrganismsMultidrug-resistant Tuberculosis TreatmentNeuropsychiatric EffectsNeuropsychiatric ManifestationsNeuropsychiatric ToxicityProspective Cohort DataPyridoxine PharmacokineticsValidated Screening Instruments
BACKGROUND: Cycloserine, or its structural analogue terizidone, has been associated with neuropsychiatric toxicity (psychosis, depression, and neuropathy). Prospective clinical data on the incidence of and risk factors for neuropsychiatric toxicity in TB patients treated with cycloserine are limited. METHODS: A prospective evaluation of neuropsychiatric toxicity was performed using validated screening tools in patients with multidrug-resistant tuberculosis treated with terizidone. Cox proportional hazard modelling was performed to explore the effects of clinical variables and measures of cycloserine pharmacokinetics in plasma. RESULTS: A total 144 participants were recruited: 86 were male and 58 were female; their median age was 35.7 years and 91 (63%) were HIV-infected. Fifty-five (38%) participants developed at least one neuropsychiatric event (30 cases per 100 person-months): 50 (35%) neuropathy, 14 (10%) depression, and 11 (8%) psychosis. Neuropathy was independently associated with cycloserine clearance ((adjusted hazard ratio 0.34 (aHR), P = 0.03)) and high-dose pyridoxine (200 mg vs 150 mg daily, aHR: 2.79, P = 0.01). CONCLUSIONS: A high incidence of early neuropsychiatric toxicity was observed in this cohort of patients treated with terizidone. Cycloserine clearance and higher doses of pyridoxine are associated with incident or worsening peripheral neuropathy.
18
Clinical implications of Brief Psychiatric Rating Scale scores
Stefan Leucht, John M. Kane, Werner Kissling et al. · The British Journal of Psychiatry · 2005 · 892 citations · Full text
Sensory neuropathy with low‐dose pyridoxine
G. Parry, Dale E. Bredesen · Neurology · 1985 · 213 citations
Medicine, Neurology, Pharmacotherapy +11
Characteristics of pyridoxine overdose neuropathy syndrome
Katharina Dalton, Michael Dalton · Acta Neurologica Scandinavica · 1987 · 165 citations
Pharmacy, Neurology, Toxicology +17
Lena S. Andersen, Anna Grimsrud, Landon Myer et al. · International Journal of Methods in Psychiatric Research · 2011 · 159 citations · Full text